These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19186235)

  • 1. Multidisciplinary care for patients with breast cancer.
    Hulvat MC; Hansen NM; Jeruss JS
    Surg Clin North Am; 2009 Feb; 89(1):133-76, ix. PubMed ID: 19186235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer. Clinical practice guidelines in oncology.
    Carlson RW; Allred DC; Anderson BO; Burstein HJ; Carter WB; Edge SB; Erban JK; Farrar WB; Goldstein LJ; Gradishar WJ; Hayes DF; Hudis CA; Jahanzeb M; Kiel K; Ljung BM; Marcom PK; Mayer IA; McCormick B; Nabell LM; Pierce LJ; Reed EC; Smith ML; Somlo G; Theriault RL; Topham NS; Ward JH; Winer EP; Wolff AC;
    J Natl Compr Canc Netw; 2009 Feb; 7(2):122-92. PubMed ID: 19200416
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevention, detection, and management of breast cancer.
    Houssami N; Cuzick J; Dixon JM
    Med J Aust; 2006 Mar; 184(5):230-4. PubMed ID: 16515434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant and Adjuvant Therapies for Breast Cancer.
    Apuri S
    South Med J; 2017 Oct; 110(10):638-642. PubMed ID: 28973704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of early breast cancer--the current approach.
    Brennan M; Wilcken N; French J; Ung O; Boyages J
    Aust Fam Physician; 2005 Sep; 34(9):755-60. PubMed ID: 16184208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and future prospects for breast cancer therapy].
    Sonoo H
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():391-5. PubMed ID: 17682182
    [No Abstract]   [Full Text] [Related]  

  • 7. National Breast Cancer Audit: overview of invasive breast cancer in New Zealand.
    Ooi CW; Campbell ID; Kollias J; de Silva P
    N Z Med J; 2012 Aug; 125(1359):7-16. PubMed ID: 22932509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.
    Pruthi S; Boughey JC; Brandt KR; Degnim AC; Dy GK; Goetz MP; Perez EA; Reynolds CA; Schomberg PJ; Ingle JN
    Mayo Clin Proc; 2007 Sep; 82(9):1131-40. PubMed ID: 17803883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case records of the Massachusetts General Hospital. Case 25-2009. A 36-year-old woman with hormone-receptor-positive breast cancer.
    Burstein HJ; Souter I; D'Alessandro HA; Sgroi DC
    N Engl J Med; 2009 Aug; 361(7):699-707. PubMed ID: 19675333
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on the management of early-stage breast cancer.
    Heilat GB; Brennan ME; French J
    Aust J Gen Pract; 2019 Sep; 48(9):604-608. PubMed ID: 31476829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer: personalised care].
    Pouillart P
    Rev Prat; 2004 Apr; 54(8):827-9. PubMed ID: 15274452
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
    Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
    Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of treatment for early-stage invasive breast cancer].
    Kásler M; Polgár C; Fodor J
    Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Slow progress in therapy of breast carcinoma].
    Aumiller J
    MMW Fortschr Med; 2004 Jan; 146(3-4):4-6, 8, 10. PubMed ID: 15035437
    [No Abstract]   [Full Text] [Related]  

  • 15. HER2-positive early breast cancer and trastuzumab: a surgeon's perspective.
    Kulkarni S; Hicks DG
    Ann Surg Oncol; 2008 Jun; 15(6):1677-88. PubMed ID: 18398661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neoadjuvant systemic therapy in breast cancer].
    Kahán Z; Nikolényi A; Uhercsák G; Thurzó L
    Orv Hetil; 2009 Jan; 150(2):65-71. PubMed ID: 19103557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
    Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic advances in breast cancer].
    Pestalozzi BC
    Ther Umsch; 2006 Apr; 63(4):255-61. PubMed ID: 16689456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.
    Arsenault D; Hurley J; Takita C; Reis IM; Zhao W; Rodgers S; Wright JL
    Am J Clin Oncol; 2015 Aug; 38(4):348-52. PubMed ID: 23799288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute.
    van der Leij F; van Werkhoven E; Bosma S; Linn SC; Rutgers EJ; van de Vijver MJ; Bartelink H; Elkhuizen PHM; Scholten A
    Breast; 2016 Dec; 30():19-25. PubMed ID: 27587341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.